39 results on '"Massabeau C"'
Search Results
2. Surface-guided radiotherapy overview: Technical aspects and clinical applications
3. OC-0261 Impact of radiation to host immune system in patients treated for locally advanced NSCLC
4. PO-1272 SBRT for oligoprogressive/oligorecurrent SCLC: is it worth it?
5. PD-0749 Systemic treatment and ablative therapies in oligometastatic breast cancer: a single center analysis
6. Prise en charge des cancers bronchiques non à petites cellules oligométastatiques
7. Traitements locaux : indication et résultats dans les stades précoces
8. 320P Oligometastatic breast cancer incidence and clinical presentation at diagnosis: About 131 cases
9. Fracture de côte suite à la radiothérapie peropératoire dans le cancer du sein. Cas clinique et expérience locale
10. Les cancers bronchiques non à petites cellules oligométastatiques: définition et prise en charge
11. La radiothérapie stéréotaxique: indication et résultats dans les stades précoces
12. Cours du GOLF 2018 à Toulouse, France
13. OC-0594 Acute toxicity results after breast-conserving therapy in “boost vs no boost (BONBIS)” DCIS trial
14. Helical Tomotherapy (HT) for Postmastectomy Radiation Therapy (PMRT) Treatment after Implant Breast Reconstruction
15. Radiothérapie guidée par l’image dans le cancer du poumon
16. Toxicité aiguë de la tomothérapie des cancers mammaires
17. PO-0812: Dosimetric impact of using Acuros algorithm for stereotactic lung and spine treatments
18. Variabilité multicentrique de l’estimée du volume tumoral métabolique total en TEP au FDG dans le cadre du PHRC multicentrique RTEP7-IFCT-1402
19. P13. Spine SBRT: Benefit of Magnetic Resonance Imaging acquisition in treatment position and first results of Volumetric Modulated Arc Therapy dose plan
20. PO-0685: Locally advanced breast cancer patients with >7 pN+ axillary lymph nodes treated without axillary irradiation
21. SP-0598: Cilengitide in continuous infusion with radio-chemotherapy in stage III NSCLC: A phase I clinical trial
22. Outcome of pN0 Triple-Negative Breast Cancers With and Without Lymph Node Irradiation
23. Continuous Infusion of Cilengitide with Radio-Chemotherapy in Stage III Nsclc: a Phase I Study
24. Carcinome canalaire in situ avec micro-invasion : spécificités anatomopathologiques et implications cliniques
25. Que faut-il associer à la radiothérapie dans les stades III des CBNPC et comment ?
26. Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient: Case report and review of the literature
27. Rapidarc vs. tomotherapy for the treatment of chestwall and lymph nodes: A comparative study
28. SP-25: Continuous Infusion of Cilongitide with Radiochemotherapy in State III NSCL Carcinoma = A Phase 1 Study
29. Potential benefits of using cardiac gated images to reduce the dose to the left anterior descending coronary during radiotherapy of left breast and internal mammary nodes
30. 761 poster IMPLANT BREAST RECONSTRUCTION FOLLOWED BY RADIOTHERAPY: CAN THE TOMOTHERAPY BECOME A STANDARD OF IRRADIATION?
31. 769 poster POTENTIAL BENEFITS OF USING CARDIAC GATED IMAGES TO REDUCE THE DOSE TO THE LEFT ANTERIOR DESCENDING CORONARY DURING RADIOTHERAPY OF LEFT BREAST AND INTERNAL MAMMARY NODES
32. Blood Vessel Invasion on Pre Treatment Biopsies Predicted Poor Prognosis in Patients with Advanced Non–small-cell Lung Carcinoma Treated with Radio and Chemotherapy
33. Les progrès de la radiothérapie dans la prise en charge des cancers bronchiques
34. Radiothérapie externe ou surveillance des séminomes testiculaires de stade 1 : comparaison des doses d’irradiation délivrées au testicule restant
35. Chimioradiothérapie des cancers bronchiques non à petites cellules – la présence d’emboles sur biopsies est un facteur pronostique des cancers
36. 161 Combining the adhesion pathway inhibition with radiotherapy – from the bench to the clinic
37. BLOOD VESSEL INVASION PREDICTED POOR PROGNOSIS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CARCINOMA TREATED WITH RADIO AND CHEMO-THERAPY
38. α3 integrin/FGF-2 expression profile: signature of local progression after chemo- radiotherapy for patients with NSCLC
39. L'expression deFGF-2 prédit laréponse tumorale etlecontrôle local descancers bronchiques non àpetites cellules après chimioradiothérapie
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.